$CL
Colgate-Palmolive Company · NYSE · Consumer Defensive
- Market cap
- 74.97B
- Volume
- 4.73M
- P/E
- 37.02
- Day range
- 93.68 – 97.23
- 52w range
- 74.55 – 99.33
- Analyst target
- 98.15
AI Summary
Generating a unique summary for CL…
AI-generated for information only — not investment advice.
Share this ticker
$CL -3.44% at 94.04 Bill Ackman and 2 other tracked billionaires hold it. https://billionairestrading.com/stocks/CL
Company summary
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Institutional ownership
Institutions hold 86.38% · insiders 0.15% · 2,665 institutions
| Holder | Shares | Value | % held | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 69.92M | $6.57B | 8.77% | 2026-06-30 |
| Vanguard Capital Management LLC | 52.25M | $4.91B | 6.55% | 2026-06-30 |
| State Street Corporation | 47.02M | $4.42B | 5.90% | 2026-06-30 |
| Price (T.Rowe) Associates Inc | 27.91M | $2.62B | 3.50% | 2026-06-30 |
| Vanguard Portfolio Management LLC | 24.02M | $2.26B | 3.01% | 2026-06-30 |
| Geode Capital Management, LLC | 23.14M | $2.18B | 2.90% | 2026-06-30 |
| Morgan Stanley | 22.07M | $2.08B | 2.77% | 2026-06-30 |
| Bank Of New York Mellon Corporation | 13.53M | $1.27B | 1.70% | 2026-06-30 |
| Deutsche Bank AG | 11.75M | $1.11B | 1.47% | 2026-06-30 |
| NORGES BANK | 9.69M | $910.87M | 1.22% | 2026-06-30 |
Hedge fund & billionaire activity
Insider transactions
| Insider | Role | Transaction | Shares | Date |
|---|---|---|---|---|
| TSOURAPAS PANAGIOTIS | Officer | Sale at price 92.05 per share. | 10.0K | 2026-08-24 |
| CAHILL JOHN T | Director | Conversion of Exercise of derivative security at price 71.56 per share. | 4.2K | 2026-08-06 |
| CAHILL JOHN T | Director | Sale at price 93.37 per share. | 4.2K | 2026-08-06 |
| WALLACE NOEL R | Chief Executive Officer | Conversion of Exercise of derivative security at price 72.29 per share. | 322.0K | 2026-08-05 |
| WALLACE NOEL R | Chief Executive Officer | Sale at price 91.92 - 92.52 per share. | 322.0K | 2026-08-05 |
| BILBREY JOHN P. | Director | Stock Award(Grant) at price 89.45 per share. | 265.00 | 2026-07-01 |
| NEWMAN BRIAN | Director | Stock Award(Grant) at price 89.45 per share. | 209.00 | 2026-07-01 |
| NORRINGTON LORRIE M | Director | Stock Award(Grant) at price 89.45 per share. | 293.00 | 2026-07-01 |
| MALCOLM GREGORY | Officer | Sale at price 88.44 per share. | 2.3K | 2026-05-15 |
| BILBREY JOHN P. | Director | Stock Award(Grant) at price 0.00 per share. | 2.1K | 2026-05-11 |
| HUND-MEJEAN MARTINA | Director | Stock Award(Grant) at price 0.00 per share. | 2.1K | 2026-05-11 |
| CAHILL JOHN T | Director | Stock Award(Grant) at price 0.00 per share. | 2.1K | 2026-05-11 |
Analyst ratings
Consensus score 2.10 (1 = strong buy, 5 = sell) · mean target 98.15
- JP MorganOverweightmain2026-10-19
- Wells FargoEqual-Weightmain2026-10-05
- Piper SandlerOverweightmain2026-09-21
- RBC CapitalOutperformreit2026-09-08
- UBSBuymain2026-08-03
- TD CowenHoldmain2026-08-03
- JP MorganOverweightmain2026-08-03
- RBC CapitalOutperformmain2026-08-03
- Evercore ISI GroupOutperformmain2026-08-03
- BarclaysEqual-Weightmain2026-07-21
Earnings
Next report: 2026-10-30
| Quarter | EPS actual | EPS estimate | Surprise |
|---|---|---|---|
| 3Q2025 | 0.91 | 0.89 | 0.02 |
| 4Q2025 | 0.95 | 0.91 | 0.04 |
| 1Q2026 | 0.97 | 0.94 | 0.03 |
| 2Q2026 | 0.99 | 0.95 | 0.04 |
SEC filings
- 10-QPeriodic Financial Reports2026-07-31Open
- 11-KAnnual report of employee stock purchase2026-06-24Open
- SDSpecialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)2026-06-01Open
- 8-KCorporate Changes & Voting Matters2026-05-13Open
- 8-KCorporate Changes & Voting Matters2026-05-01Open
- DEFA14AProxy Statements2026-04-16Open
- 8-KCorporate Changes & Voting Matters2026-04-09Open
- DEFA14AProxy Statements2026-03-25Open
- 8-KCorporate Changes & Voting Matters2026-03-17Open
- 8-KCorporate Changes & Voting Matters2026-03-12Open
Latest CL news
- Colgate-Palmolive (CL) Faces A Leadership Exit On A Pricey Earnings Narrative
Recent optimism around Colgate-Palmolive (CL) is being tested by a fresh development in its India unit, where long-serving marketing head Gunjit Jain is set to exit after 18 years. For context, Colgate-Palmolive’s share price has eased 3.44% over the past day, yet it still carries a 9.44% 30 day share price return and a 21.05% year to date share price gain. The 1 year total shareholder return of 23.46% points to momentum that has been building over a longer stretch. Scan how other...
Sat, 24 Oct 2026 17:07:56 +0000
- How Earnings Optimism At Colgate Palmolive Stock Has Changed Its Investment Story
Colgate-Palmolive India appointed long-time insider Akash Parekh as executive vice president, marketing, effective December 1, 2026, following the departure of 18 year veteran Gunjit Jain on November 30, 2026. Parekh’s deep experience across India, North America and Asia Pacific, along with his regional marketing remit, points to continuity in how Colgate-Palmolive executes premium positioning, demand creation and brand strategy in key oral and personal care categories. We will now look at...
Sat, 24 Oct 2026 16:10:49 +0000
- Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?
One is a growth stock but faces Pepsi dependency; the other is a more mature company but has massive operating cash flow.
Sat, 24 Oct 2026 00:50:02 +0000
- Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fri, 23 Oct 2026 13:00:02 +0000
- Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thu, 22 Oct 2026 15:10:02 +0000
- Clorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap?
Clorox's nearly 6% yield towers over Colgate's modest payout, making it look like a retiree's dream income stock. But a closer look at the balance sheet and cash flow tells a very different story about which company actually deserves a place in your portfolio.
Tue, 20 Oct 2026 12:15:17 +0000
- 3 Defensive Stocks to Buy as the AI Selloff Rattles Wall Street
The recent AI sell-off shows why diversification matters. Here are three stocks that can help investors diversify their portfolios.
Fri, 23 Oct 2026 11:30:02 +0000
- Coca Cola Stock And Other Consumer Staples With Pricing Power
The market is holding its breath ahead of the Fed meeting, fresh PCE inflation data, and new GDP and earnings clues. That mix is putting quiet pressure on the kinds of companies investors rely on when growth cools and borrowing costs stay high. Defensive consumer staples now sit at the intersection of those forces. This article explains how three large U.S. stocks from that group could be positioned, and why their reaction to this macro environment may matter for your portfolio more than the...
Sat, 24 Oct 2026 12:13:33 +0000